Cartesian Therapeutics, Inc.
RNAC
$10.78
-$0.47-4.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.26M | -38.31M | -77.42M | -244.83M | -229.65M |
| Total Depreciation and Amortization | 2.52M | 2.12M | 1.15M | 937.00K | 840.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.26M | 11.83M | 58.39M | 220.48M | 208.34M |
| Change in Net Operating Assets | 24.07M | -6.50M | -5.79M | -16.55M | -42.39M |
| Cash from Operations | -33.94M | -30.87M | -23.67M | -39.96M | -62.86M |
| Capital Expenditure | -10.57M | -9.57M | -9.09M | -8.45M | -2.25M |
| Sale of Property, Plant, and Equipment | 351.00K | 351.00K | 351.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | 6.56M | 6.56M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -10.22M | -9.22M | -8.74M | -1.89M | 4.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -24.87M |
| Issuance of Common Stock | 125.61M | 125.65M | 128.49M | 127.65M | 3.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 40.00M | 60.25M | 60.25M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.30M | -8.27M | -66.00K | -6.17M | -6.17M |
| Cash from Financing | 117.31M | 117.37M | 168.43M | 181.73M | 32.44M |
| Foreign Exchange rate Adjustments | 14.00K | 16.00K | -21.00K | 10.00K | 5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.16M | 77.31M | 135.99M | 139.89M | -26.11M |